Citadel Advisors
SRTA

Citadel Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

Citadel Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Buy
372,941
+118,130
+46% +$569K ﹤0.01% 6631
2025
Q4 		$1.23M Buy
254,811
+102,460
+67% +$496K ﹤0.01% 6954
2025
Q3 		$771K Buy
152,351
+31,015
+26% +$137K ﹤0.01% 8114
2025
Q2 		$489K Sell
121,336
-300,126
-71% -$977K ﹤0.01% 8682
2025
Q1 		$1.15M Sell
421,462
-522,620
-55% -$1.87M ﹤0.01% 6654
2024
Q4 		$4.01M Buy
944,082
+772,910
+452% +$2.94M ﹤0.01% 4330
2024
Q3 		$503K Buy
171,172
+145,866
+576% +$464K ﹤0.01% 8244
2024
Q2 		$88.1K Sell
25,306
-221,213
-90% -$738K ﹤0.01% 11094
2024
Q1 		$703K Buy
246,519
+246,186
+73,930% +$760K ﹤0.01% 7659
2023
Q4 		$1.18K Sell
333
-126,829
-100% -$364K ﹤0.01% 13867
2023
Q3 		$329K Buy
127,162
+101,810
+402% +$358K ﹤0.01% 8985
2023
Q2 		$99.9K Buy
+25,352
New +$80.4K ﹤0.01% 10946
2023
Q1 		– Sell
-140,279
Closed -$572K – 14727
2022
Q4 		$502K Buy
140,279
+13,227
+10% +$56.5K ﹤0.01% 8223
2022
Q3 		$512K Sell
127,052
-15,054
-11% -$77.3K ﹤0.01% 8401
2022
Q2 		$634K Buy
142,106
+69,479
+96% +$501K ﹤0.01% 8114
2022
Q1 		$616K Buy
72,627
+55,854
+333% +$392K ﹤0.01% 8890
2021
Q4 		$148K Buy
16,773
+6,081
+57% +$57.8K ﹤0.01% 12274
2021
Q3 		$111K Sell
10,692
-175,365
-94% -$1.53M ﹤0.01% 12742
2021
Q2 		$1.95M Buy
186,057
+179,145
+2,592% +$1.77M ﹤0.01% 6681
2021
Q1 		$71K Sell
6,912
-302,509
-98% -$4.21M ﹤0.01% 12720
2020
Q4 		$3.43M Buy
+309,421
New +$3.16M ﹤0.01% 4355

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors's SRTA Position: Q1 2026 in Review

Citadel Advisors increased its Strata Critical Medical Inc (SRTA) stake by 46% in Q1 2026, buying an estimated $569K and bringing the position to 372,941 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #6631.

Citadel Advisors first reported a position in SRTA in Q4 2020 and has held it in 21 quarters since. The position peaked at $4.01M in Q4 2024. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Citadel Advisors held 372,941 shares of Strata Critical Medical Inc worth $1.56M as of Q1 2026.
  • Citadel Advisors bought 118,130 Strata Critical Medical Inc shares in Q1 2026, an estimated $569K.
  • Strata Critical Medical Inc made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6631 holding.
  • Citadel Advisors first reported a position in Strata Critical Medical Inc in Q4 2020 and has held it in 21 quarters since.
  • Citadel Advisors's Strata Critical Medical Inc position peaked at $4.01M in Q4 2024.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.